I agree it's almost impossible to reconcile the SP with the fundamentals.
I personally don't have an issue waiting for results or approvals provided we have the cash to get us there. A partnership with BP to fund the trials and then share revenue/profit would be absolutely ideal and I'm hopeful this will be the case. If not we are not in a great position to raise cash.
I too suspect something more is at play. The selling pressure is relentless especially following a good announcement, almost like someone wants to drive the price down. I hope the consolidation is approved and it tightens up the registry and makes it harder to manipulate.
IMO as long as we can fund our trials we'll be fine. Azer Cell getting approval as the first or one of the first allogeneic CarT's would have to be worth 2 Billion US. That's just over 30 cents a share pre consolidation. I'd be more than happy to wait the 2-3 years for that result considering that's placing no value on the rest of the pipeline.
IMU Price at posting:
1.2¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)